WakabayashiH, HamaguchiT, NagaoN. Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line. Breast Cancer. 2018 September;25(5):566-574
2.
MasjediA, HashemiV, Hojjat-FarsangiM. The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer. Biomed Pharmacother. 2018 October 6;108:1415-1424.
3.
WangCZ, YuanP, LiY.MiR-126 regulated breast cancer cell invasion by targeting ADAM9. Int J Clin Exp Pathol. 2015 June 1;8(6):6547-6553.
4.
WuY, SongLT, LiJS. MicroRNA-126 regulates inflammatory cytokine secretion in human gingival fibroblasts under high glucose via targeting tumor necrosis factor receptor associated factor 6. J Periodontol. 2017 November;88(11):e179-e187.
5.
ChuX, GuY, ShengW, SunJ. Downregulation of miR-126-3p expression contributes to increased inflammatory response in placental trophoblasts in preeclampsia. J Reprod Immunol. 2021 April;144:103281.
6.
ShenH, LiL, YangS, WangD. Regulatory role of tumor necrosis factor receptor-associated factor 6 in breast cancer by activating the protein kinase B/glycogen synthase kinase 3β signaling pathway. Mol Med Rep. 2017 August;16(2):2269-2273.
